ANDA 89586, held by Sandoz. Fluphenazine Hydrochloride.
As of Nov 21, 2026, ANDA 89586 (Fluphenazine Hydrochloride), held by Sandoz, was first approved by FDA on Oct 16, 1987, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 16, 1987 | Original application | Approved | None posted |
| Fluphenazine Hydrochloride10MG · tablet;oral | Fluphenazine Hydrochloride | Discontinued |
| Fluphenazine Hydrochloride1MG · tablet;oral | Fluphenazine Hydrochloride | Discontinued |
| Fluphenazine Hydrochloride2.5MG · tablet;oral | Fluphenazine Hydrochloride | Discontinued |
| Fluphenazine Hydrochloride5MG · tablet;oral | Fluphenazine Hydrochloride | Discontinued |
| Jan 22, 2025 | Supplement 25Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 23Labeling · Standard review | Approved | None posted |
| Oct 19, 2011 | Supplement 22Labeling | Approved | None posted |
| Dec 3, 2010 | Supplement 21Labeling | Approved | None posted |
| Jul 7, 2009 | Supplement 19Labeling | Approved | None posted |
| Jan 23, 2009 | Supplement 18Labeling | Approved | None posted |
| May 29, 2008 | Supplement 14Labeling | Approved | None posted |
| May 5, 1999 | Supplement 9Manufacturing | Approved | None posted |
| Oct 8, 1998 | Supplement 6Manufacturing | Approved | None posted |
| Oct 8, 1998 | Supplement 7Labeling | Approved | None posted |
| Sep 15, 1998 | Supplement 8Manufacturing | Approved | None posted |
| Oct 20, 1995 | Supplement 5Manufacturing | Approved | None posted |
| Feb 2, 1995 | Supplement 4Manufacturing | Approved | None posted |
| Nov 1, 1988 | Supplement 1Labeling | Approved | None posted |
| Nov 1, 1988 | Supplement 2Manufacturing | Approved | None posted |
| Nov 1, 1988 | Supplement 3Labeling | Approved | None posted |
| Oct 16, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters